Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Align TechnologySTU:AFW +1.07%84 Equity-to-Asset is 0.66 as of Jun. 2026, which is 6% above its 10-year median of 0.62. GuruFocus rates STU:AFW with a GF Score™ of 84/100 and a GF Value™ of €192.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Align Technology ranks better than 54.05% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Align Technology's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €3,674 Mil. Align Technology's Total Assets for the quarter that ended in Jun. 2026 was €5,570 Mil.
Therefore, Align Technology's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.66.
The historical rank and industry rank for Align Technology's Equity-to-Asset or its related term are showing as below:
STU:AFW'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.54 Med: 0.62 Max: 0.72
Current: 0.66
During the past 13 years, the highest Equity to Asset Ratio of Align Technology was 0.72. The lowest was 0.54. And the median was 0.62.
STU:AFW's Equity-to-Asset is ranked better than 54.05% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs STU:AFW: 0.66
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Align Technology Equity-to-Asset Related Terms
Align Technology Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Align Technology's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:AFW vs RGEN, AVTR, BAX: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Align Technology's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Align Technology Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Align Technology's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Align Technology's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Align Technology (STU:AFW) has a Equity-to-Asset of 0.66 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Align Technology and its competitors. This is near median its historical median of 0.62. Over the past decade, Align Technology's Equity-to-Asset has ranged from 0.54 to 0.72. According to the industry distribution chart, Align Technology ranks #391 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 45.9%.
Is Align Technology's Equity-to-Asset too high?
Align Technology's current Equity-to-Asset of 0.66 is near median its 10-year median of 0.62. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 0.72. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Align Technology's value of 0.66 is 3.1% above this industry median. Based on the distribution chart, Align Technology ranks #391 out of 851 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Align Technology has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Align Technology's Equity-to-Asset compare to RGEN and AVTR?
According to the Medical Devices & Instruments industry distribution chart, Align Technology ranks #391 out of 851 companies for Equity-to-Asset. This puts Align Technology in the upper half of its industry. The industry median Equity-to-Asset is 0.64. Align Technology's value of 0.66 is 3.1% above this benchmark. Historically, Align Technology's own Equity-to-Asset has ranged from 0.54 to 0.72 over the past decade. While the company's 10-year median is 0.62 vs. the industry median of 0.64, Align Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Align Technology's current Equity-to-Asset of 0.66 is 3.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Align Technology and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Align Technology's current Equity-to-Asset is 0.66, which is near median its own 10-year median of 0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Align Technology stock overvalued right now?
Based on GuruFocus' analysis, Align Technology (STU:AFW) is currently considered Modestly Undervalued. The stock's GF Value™ is €192.91, compared to a current price of €137.40 — trading 28.8% below its estimated fair value. The current Equity-to-Asset is 0.66, which is near median its 10-year median of 0.62 and 3.1% above the Medical Devices & Instruments industry median of 0.64. Align Technology's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Align Technology (STU:AFW), the current Equity-to-Asset is 0.66 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Align Technology (STU:AFW) Overvalued in 2026?
Based on GuruFocus' analysis, Align Technology stock appears to be undervalued.
The current stock price of €137.40 is trading 28.8% below its estimated GF Value™ of €192.91.
GuruFocus considers Align Technology to be Modestly Undervalued.
Key valuation signals for STU:AFW:
Equity-to-Asset: 0.66 (near median its 10-year median of 0.62)
GF Value™: €192.91 vs. price of €137.40 (28.8% below fair value)
Industry Position: 3.1% above the Medical Devices & Instruments median (#391 of 851)
No single metric tells the full story. See the STU:AFW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
84GF Score
Get the complete analysis for STU:AFW
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AFW has been successfully added to your 
